Estudo de belzutifan versus everolimo em participantes com carcinoma avançado de células renais
The primary objective of this study is to compare belzutifan to everolimus with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed